TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pfizer AB
Closing information (x1000 EUR)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
168,945
|
187,696
|
383,352 |
| Financial expenses |
260
|
157
|
296 |
| Earnings before taxes |
5,580
|
10,248
|
4,029 |
| EBITDA |
5,660
|
10,112
|
20,590 |
| Total assets |
103,330
|
94,096
|
165,962 |
| Current assets |
101,466
|
91,559
|
163,835 |
| Current liabilities |
66,026
|
53,012
|
131,257 |
| Equity capital |
37,304
|
41,083
|
34,705 |
| - share capital |
3,100
|
3,124
|
3,268 |
| Employees (average) |
158
|
155
|
145 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
36.1%
|
43.7%
|
20.9% |
| Turnover per employee |
1,069
|
1,211
|
2,644 |
| Profit as a percentage of turnover |
3.3%
|
5.5%
|
1.1% |
| Return on assets (ROA) |
5.7%
|
11.1%
|
2.6% |
| Current ratio |
153.7%
|
172.7%
|
124.8% |
| Return on equity (ROE) |
15.0%
|
24.9%
|
11.6% |
| Change turnover |
-17,331
|
-178,746
|
322,002 |
| Change turnover % |
-9%
|
-49%
|
525% |
| Chg. No. of employees |
3
|
10
|
62 |
| Chg. No. of employees % |
2%
|
7%
|
75% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.